v3.22.2.2
Condensed Consolidated Statements of Cash Flows
$ in Thousands, $ in Thousands
 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Cash flows from operating activities:    
Net loss $ (10,415) $ (14,429)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 151 147
Common shares issued to vendor for services 230 186
Amortization of right of use asset 197 164
Stock-based compensation 318 6,097
Loss on foreign currency transactions 3,131 799
Change in operating assets and liabilities:    
Accounts receivable, net (21) 19
Research & development tax credit receivable 104 46
Prepaid expenses and other current assets (311) (614)
Accounts payable and accrued expenses (29) 478
Lease liabilities (190) (196)
Other assets   2
Net cash used in operating activities (6,835) (7,301)
Cash flows from investing activities:    
Purchases of property, plant and equipment (67) (282)
Net cash used by investing activities (67) (282)
Cash flows from financing activities:    
Proceeds from term loan payable   738
Repayment of term loan payable   (738)
Proceeds from the issuance of common stock and warrants in private placement   24,638
Proceeds from the issuance of common stock in private placement 2,000  
Payment of issuance costs (170) (2,454)
Proceeds from the exercise of stock options   20
Net cash provided by financing activities 1,830 22,204
Effect of exchange rate changes on cash (850) (666)
Net change in cash (5,922) 13,955
Cash and cash equivalents, beginning of period 12,226 764
Cash and cash equivalents, end of period 6,304 14,719
Supplemental disclosure of cash and non-cash investing and financing activities    
Cash paid for interest   19
Right of use asset and lease liability additions $ 583 $ 86

Source

PDF HTML 10-Q Filing
ZIP XLS HTML XBRL